Maryland
Alzheimer's disease clinical trials in Maryland
18 Alzheimer's disease studies are recruiting participants at sites in 5 cities across Maryland as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Maryland city with a recruiting study
Baltimore (12), Bethesda (2), Gaithersburg (2), Germantown (1), Pikesville (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Maryland
Basic details from each study's public record (the 12 most recently updated of 18). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)
- Observational
- Ages 55 to 110
- All sexes
- Sponsor
- National Institute on Aging (NIA)
- Recruiting in
- Baltimore
- Registry record
- NCT07099053 · updated
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
- Phase 1
- Ages 50 to 100
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Recruiting in
- Bethesda
- Registry record
- NCT07169630 · updated
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
- Phase 2
- Ages 65 to 120
- All sexes
- Sponsor
- National Institute on Aging (NIA)
- Recruiting in
- Baltimore
- Registry record
- NCT07721467 · updated
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
- No phase
- Ages 60 to 100
- All sexes
- Sponsor
- Johns Hopkins University
- Recruiting in
- Baltimore
- Registry record
- NCT06930560 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Gaithersburg
- Registry record
- NCT07011732 · updated
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Recruiting in
- Gaithersburg
- Registry record
- NCT06159673 · updated
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Recruiting in
- Bethesda
- Registry record
- NCT04396873 · updated
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Phase 2
- Ages 55 to 80
- All sexes
- Sponsor
- Lighthouse Pharmaceuticals, Inc.
- Recruiting in
- Pikesville
- Registry record
- NCT06847321 · updated
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
- Early Phase 1
- Ages 18 to 85
- All sexes
- Sponsor
- Johns Hopkins University
- Recruiting in
- Baltimore
- Registry record
- NCT04123314 · updated
Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Johns Hopkins University
- Recruiting in
- Baltimore
- Registry record
- NCT05556395 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Recruiting in
- Baltimore
- Registry record
- NCT06563895 · updated
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Johns Hopkins University
- Recruiting in
- Baltimore
- Registry record
- NCT04601038 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Maryland on ClinicalTrials.gov.
Ask about studies in Maryland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections